key: cord-0275882-564pjy2x
authors: Nosrati, E.; Dowd, J. B.; Marmot, M.; King, L. P.
title: Structural adjustment programmes and communicable disease burdens: causal evidence from 187 countries
date: 2021-03-20
journal: nan
DOI: 10.1101/2021.03.12.21253462
sha: fcf0cb5cc8c369ce126da8c8b2b8a7bd0fcf9fe1
doc_id: 275882
cord_uid: 564pjy2x

International financial organisations like the International Monetary Fund (IMF) play a central role in shaping the developmental trajectories of low- and middle-income countries through their conditional lending schemes, known as "structural adjustment programmes". These programmes entail wide-ranging domestic policy reforms that influence local health and welfare systems. Using novel panel data from 187 countries and an instrumental variable technique, we find that IMF programmes cause over 400 excess deaths and over 4,100 excess disability-adjusted life years (DALYs) from communicable diseases per 100,000 population. IMF-mandated privatisation reforms cause over 570 excess deaths and over 6,700 excess DALYs per 100,000 population. Structural adjustment programmes, as currently designed and implemented, are harmful to population health and increase communicable disease burdens in developing contexts.

austerity and rapid privatisation reforms (2, 3) . More generally, IMF-mandated policy reformsknown as "conditionalities" -have been associated with reduced state capacities and declining population health (4) (5) (6) . However, with the exception of a few case studies (7, 8), we are not aware of any prior systematic investigations of the causal relation between the IMF's structural adjustment programmes and communicable disease burdens. The purpose of our paper is to step 5 into this breach by using previously unavailable data and a compound instrumentation technique to derive unbiased causal effect estimates.

We use two alternative outcome variables: the age-standardised mortality rate from communicable diseases and the burden of communicable disability-adjusted life years (DALYs) per 100,000 10 population in 187 non-high-income countries between 1990 and 2017 (9) . We employ two sets of treatment variables to assess the effects of structural adjustment (10) . On the one hand, we use a dichotomous indicator of whether a country is under an IMF programme to estimate an overall average treatment effect of IMF intervention. On the other hand, to further probe the specific nature of structural loan conditions and their relation to the outcome variables, we assess the role of IMF-and remove these controls one by one and inspect the corresponding change in the treatment coefficient. As displayed in the remaining rows of Tables 1 and 2, we find that structural adjustment remains a robust predictor of both outcome variables. The greatest attenuation in the estimated treatment effect occurs when controlling for foreign reserves -which is a strong predictor of selection into IMF programmes -and (egalitarian) democracy -which may itself be 5 affected by IMF policies through wide-ranging institutional reforms and weakened state capacity (4, 21) .

Given the observational nature of our study, the persistence of unmeasured residual confounding is possible. To address this concern, we conduct a simple non-parametric sensitivity analysis that 10 allows us to quantify the amount of unmeasured confounding that would in theory be required to eliminate our estimated causal effect (see Supplementary Materials for methodological details). The results of this sensitivity analysis are visualised in Fig. 1 . The X-axis ranges from 0 to 1, with higher values indicating a higher prevalence of some unmeasured confounder U in the treatment group (i.e., in countries with IMF programmes). We label this variable d. The Y-axis quantifies 15 the net effect of U on the outcome variable that would be required to completely eliminate the estimated causal effect of structural adjustment programmes. In light of our instrumented treatment variable, we believe it is plausible that the amount of residual confounding remains moderate. As such, the most likely magnitude of d would be at the lower end of the X-axis in Figure 1 . If d = 0.1, U would have to cause around 4,000 excess deaths and over 40,000 excess DALYs per 20 100,000 population to nullify the effect of IMF programmes, which seems implausible. Even at higher values of d, a substantial amount of unmeasured confounding would be needed to cast doubt on our causal estimates.

We proceed to the analysis of IMF-mandated privatisation reforms. To facilitate interpretation, we 25 dichotomise the treatment variable. Our baseline models are shown in the first rows of Tables 3  and 4 , according to which privatisation reforms lead to 576 excess communicable disease deaths (95% CI: 299-852; P = 0.00005) and 6,716 excess DALYs (95% CI: 3,265-10,167; P = 0.0002) per 100,000 population. These estimates are robust to additional controls, though the effect sizes are most strongly attenuated when adjusting for the incidence of coups d'état (in the first model) 30 and for foreign reserves (in the second model). The corresponding sensitivity analysis is visualised in Fig. 2 , suggesting once again that unusually high levels of bias are required to eliminate our estimated causal effects. If we assume, for the sake of argument, that our unadjusted effect sizes overestimate the true causal effect by as much as 100 excess deaths and 1,000 excess DALYs, then the bias-adjusted parameter estimates would still be 476 excess deaths (95% CI: 199-752; P = 35 0.0008) and 5,716 excess DALYs (95% CI: 2,265-9,167; P = 0.001) per 100,000 population, respectively.

Our analysis provides novel causal evidence from previously unavailable cross-national panel 40 data, linking the IMF's interventions in developing countries to poor health outcomes. We corroborate earlier studies and hypotheses surrounding this topic, yet we offer new empirical insights. We note that the observational nature of our analysis precludes any guarantee of strictly . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.12.21253462 doi: medRxiv preprint unbiased causal estimates. However, the sensitivity analysis suggests that an unusual amount of unmeasured confounding would be required to cast serious doubt on our substantive findings. We are unable to specify the mechanisms by which the estimated causal effects take place. The extant literature, however, suggests that IMF programmes affect healthcare system and exert durable influence on the social determinants of health (1) . Moreover, the rapid privatisation of state-owned 5 enterprises has previously been linked to turbulent labour market conditions, high levels of social insecurity and stress, and weaker public institutions (11, 12) . Such insights lend credence to our finding that IMF programmes as a whole, and especially privatisation conditionalities, have strong adverse impacts on both age-standardised all-cause mortality rates and on the total burden of disability-adjusted life years. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.12.21253462 doi: medRxiv preprint Table 1 . 10 The outcome variable is the age-standardised mortality rate from communicable diseases per 100,000 population between 1990 and 2017. Each row is a separate two-way fixed-effects regression wherein the effect of IMF programmes on the outcome variable is adjusted for the control variable listed in the first column. All models are also adjusted for country-and time-fixed effects. The IMF variable, lagged by one year, is instrumented as described in the Supplementary   15 Materials. The corresponding parameter estimate is interpreted as the excess number of deaths per 100,000 population caused by IMF programmes. Standard errors consistent with serial autocorrelation, heteroskedasticity, and unit clustering are shown in parentheses below each parameter estimate. Statistical significance levels: *P < 0.05; **P < 0.01; ***P < 0.001. 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Sensitivity analysis plot to assess residual confounding of the estimated effect of IMF programmes on mortality rates from communicable diseases and disability-adjusted life years as per Tables 1   10   . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 2 .

The outcome variable is the burden of disability-adjusted life years due to communicable diseases per 100,000 population between 1990 and 2017. Each row is a separate two-way fixed-effects regression wherein the effect of IMF programmes on the outcome variable is adjusted for the control variable listed in the first column. All models are also adjusted for country-and time-fixed effects. The IMF variable, lagged by one year, is instrumented as described in the Supplementary Materials. The corresponding parameter estimate is interpreted as the excess number of disability-15 adjusted life years per 100,000 population caused by IMF programmes. Standard errors consistent with serial autocorrelation, heteroskedasticity, and unit clustering are shown in parentheses below each parameter estimate. Statistical significance levels: *P < 0.05; **P < 0.01; ***P < 0.001. W x c n n 3 A q J g x m q Z C C V k a 5 b R 5 C 0 7 2 R k i w B y 2 L t / S P m Q 1 u g E v c M u + y 6 3 R w J 5 S 4 W f 9 9 + o G z 8 I l v r p D P Z M C n J F X H 7 g d / 7 C 5 K l b h U o T I j L y 4 0 u m t m d j k D I r s 7 F b R I + G w O 7 r f p L G q Y + T o W t T t x m L z 3 b n M P p l F W p d b V F + t k c b m 4 X u S f c 7 X j Z p 1 l y n 5 7 J 4 t / 6 q 1 Q J r 4 K j P R E H B + 7 x a 5 p 9 E R k t P R U v 1 B P Y t U V 8 k x 0 1 D G 6 g f B V 3 O j x 0 9 t 3 X s P S c t p h h B o Y h 6 2 j I 3 r C j + M L v 4 l I X 5 j T e N J n j d N 8 x 4 l p 1 x o 9 H X Q T o w K Z A r U T z z G h Y 9 9 x p 6 U j J Y 1 3 g Y 6 Q k Q Z X R 5 6 K S E i D 1 7 4 A E d z J J V / t H J T W 3 c p 6 8 W d p e e t z J k e e X t I r T l w V D / 8 3 X N n 7 J H P V X C P X z n X y H / P N v M 6 f p a H z c 9 m Y F z T 2 y 5 v / r p 2 B B g = = < / l a t e x i t >

Control coefficient 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.12.21253462 doi: medRxiv preprint Table S1

References (22-25)

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.12.21253462 doi: medRxiv preprint

We posit the following data-generating process:

where Y it denotes one of the two alternative outcome variables as measured in country i at time t; T i[t−1] is a dichotomous indicator of IMF programme participation, lagged by one year to allow for delayed effects to manifest; X is a vector of control variables; µ captures time-invariant country-specific effects; ϕ measures time-fixed effects; and ε is a stochastic error term. Our principal quantity of interest is β, which is a causal effect parameter to be estimated. However, to account for the (potentially) endogenous relation between IMF programme participation and population health, we construct an instrumental variable, Z, that is suited to isolating exogenous variation in T . To do this, we follow recent methodological advances in the study of structural adjustment (21, 22) by adopting a compound instrument derived from the interaction between the country-specific average exposure to IMF programmes over the sample period and the Fund's annual budget constraint, approximated by the number of countries with an IMF programme in a given year (23). This instrument meets the relevance criterion insofar as the IMF is likely to impose more stringent loan conditions when facing liquidity concerns. It also meets the exclusion criterion insofar as the Fund's aggregate annual budget constraints are independent of any given client country, such that unit-specific shocks that deviate from a country's long-run average exposure to structural adjustment result from a treatment assignment mechanism that is orthogonal to any given country's potential outcomes. In other words, the outcome of interest in countries with varying propensities to participate in IMF programmes will not be affected by changes in the Fund's budgetary constraint other than through the impact of structural adjustment. Our identification strategy is visually summarised in Figure S1 , where the conditional independence assumption obtains by deploying Z as a source of exogenous variation in T . We thus obtain a two-stage regression model with the following selection equation:

We then re-specify the model in equation (1) as follows, with T being a vector of fitted values from equation (2):

To empirically assess the strength of the chosen instrument, we compare the model in equation (2) to a restricted first-stage regression in which the effect τ of Z on T is set to be null, obtaining a χ 2 test statistic of 53.641 on 1 degree of freedom (p < 0.001).

1 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. ;

Our alternative instrument targeting privatisation conditionalities also passes the required significance threshold, with a χ 2 test statistic of 40.464 on 1 degree of freedom (p < 0.001). Hence, in both cases, Z comfortably satisfies the benchmark for identifying strong instruments. We control for the endogenous relation between T and Y potentially induced by any time-invariant propensity of countries with a prior health disadvantage to select into IMF programmes by adjusting for country-fixed effects, whereas year-fixed effects help account for broader aggregate changes that affect all countries simultaneously. All variance estimators are consistent with serial autocorrelation, heteroskedasticity, and country-level clustering effects. All analyses are conducted in R, version 4.0.2.

Given that we cannot empirically verify the presence of conditional exchangeability between treatment and control groups, the persistence of unmeasured residual confounding is possible. To address this concern, we conduct a simple non-parametric sensitivity analysis that allows us to quantify the amount of unmeasured confounding that would in theory be required to eliminate our estimated treatment effectβ. As per Figure S1 , let U denote an unmeasured confounder. Then the bias factor, B, is defined as the difference betweenβ and whatβ would have been had we controlled for U as well. Assuming U is binary, we define

as the net effect of the unmeasured confounder on the outcome and δ = P(U = 1 | T = 1) − P(U = 1 | T = 0) as the difference in the prevalence of the unmeasured confounder between the treatment and control groups. Then the bias factor is the product of these two sensitivity parameters: B = γ × δ (24, 25). In assessing the sensitivity of our model coefficients to unmeasured confounding, we ask how large γ would have to be in order to reduce our estimated effect sizeβ to zero. We address this question by visualising how B changes as the two sensitivity parameters (co-)vary across a range of possible values.

2 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2021. ; Figure S1 : Causal graph depicting the effect of the treatment variable (T = IMF programme) on the outcome (Y = communicable disease mortality rate or DALY burden), identified via a compound instrument (Z = country-specific average IMF programme participation × annual IMF liquidity constraint), net of both measured covariates (X) and unmeasured confounders (U ). Notes: The mortality rate from communicable diseases is age-standardised. Both the mortality rate and the disability-adjusted life years are per 100,000 population. The second column lists the number of observed country-years. The privatisation variable counts the total number of privatisation conditionalities imposed on a borrowing country by the IMF. The general democracy index ranges from −10 to 10. The egalitarian democracy index ranges from 0 to 1.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.12.21253462 doi: medRxiv preprint

Structural adjustment and health: a conceptual framework and evidence on 5 pathways

The impact of IMF conditionality on government health expenditure: A cross-national analysis of 16 West African nations

Structural adjustment and public spending on 10 health: Evidence from IMF programs in low-income countries

The world system and the hollowing out of state capacity: How structural adjustment programs affect bureaucratic quality in developing countries

The International Monetary Fund's effects on global health: before and after the 2008 financial crisis

Globalization and health equity: The impact of structural adjustment programs on developing countries

International Monetary Fund programs and tuberculosis outcomes in post-communist countries

Greece's health crisis: from austerity to denialism

Global Burden of Disease Collaborative Network. Global Burden of Disease Study

United States: Institute for

IMF conditionality and development policy space

Mass privatisation and the post-communist mortality crisis: a cross-national analysis

The effect of rapid privatisation on mortality in monoindustrial towns in post-Soviet Russia: a retrospective cohort study

World Development Indicators

Systemic Banking Crises Database. IMF